As final recommendation, the HTA Council is recommending the non-financing of the government and non-inclusion of Calcium Hydroxide + Clinoptilolite Larvicide (Kiti-kitiX) in the list of larvicides to be used by the Aedes Borne Viral Diseases (Dengue) Prevention and Control Program of the DOH due to the unavailability of sufficient clinical evidence on its efficacy, effectiveness, and safety at this point.

The HTA Council suggests further studies to be conducted in order to provide the needed evidence that addresses its decision criteria based on the Universal Health Care (UHC) Act.